Abstract
BackgroundIguratimod (T-614), a novel DMARD, was originally discovered by Toyama Chemical. The drug has been reported to have good efficacy in the ACR 20 response rate in the clinical trials...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have